Worldwide Network for Blood and Marrow Transplantation (Wbmt) Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries With Limited Resources (Part Ii): Clinical, Technical and Socio-Economic Considerations

Worldwide Network for Blood and Marrow Transplantation (Wbmt) Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries With Limited Resources (Part Ii): Clinical, Technical and Socio-Economic Considerations Publisher Pubmed

Aljurf M¹ ; Weisdorf D² ; Hashmi SK^{1, 3} ; Nassar A⁴ ; Gluckman E⁵ ; Mohty M⁶ ; Rizzo D⁷ ; Pasquini M⁷ ; Hamadani M⁷ ; Saber W⁷ ; Hari P⁷ ; Kharfandabaja M⁸ ; Majhail N⁹ ; Gerges U¹⁰ Show All Authors

Aljurf M¹
Weisdorf D²
Hashmi SK^{1, 3}
Nassar A⁴
Gluckman E⁵
Mohty M⁶
Rizzo D⁷
Pasquini M⁷
Hamadani M⁷
Saber W⁷
Hari P⁷
Kharfandabaja M⁸
Majhail N⁹
Gerges U¹⁰
Ali Hamidieh A¹¹
Hussain F¹
Elhaddad A⁴
Mahmoud HK⁴
Tbakhi A¹²
Othman TB¹³
Hamladji RM¹⁴
Bekadja MA¹⁵
Ahmed P¹⁶
Bazarbachi A¹⁷
Adil S¹⁸
Alkindi S¹⁹
Ladeb S¹³
Dennison D¹⁹
Patel M²⁰
Lu P²¹
Quessar AE²²
Okamoto S²³
Atsuta Y²⁴
Alhejazi A²⁵
Ayas M¹
Ahmed SO¹
Novitzky N²⁶
Srivastava A²⁷
Seber A²⁸
Elsolh H¹
Ghavamzadeh A¹¹
Confer D⁷
Kodera Y²⁹
Greinix H³⁰
Szer J³¹
Horowitz M⁷
Niederwieser D^{29, 32}

Show Affiliations

1. Hematology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
2. University of Minnesota, Minneapolis, MN, United States
3. Department of Medicine, Mayo Clinic, Rochester, MN, United States
4. National Cancer Institute, Cairo University, Cairo, Egypt
5. Eurocord Hopital Saint-Louis and University Paris Diderot, Paris, France
6. Hopital Saint-Antoine, Sorbonne University, Paris, France
7. Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, WI, United States
8. Department of Medicine, Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, United States
9. Blood and Marrow Transplant Program, Cleveland Clinic, Cleveland, OH, United States
10. Hematologic Malignancies & Bone Marrow Transplant, Department of Medicial Oncology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, United States
11. Tehran University of Medical Sciences, Hematology, Oncology & SCT Research Ctr., Tehran, Iran
12. King Hussein Cancer Center, Amman, Jordan
13. Center National de Greffe de Moelle Osseuse de Tunis, Tunis, Tunisia
14. Pierre and Marie Curie Center, Algiers, Algeria
15. University Hospital Establishment 1st Nov, Oran, Algeria
16. Armed Forces Institute of Transplantation, Rawalpindi, Pakistan
17. Hematology/Oncology, American University of Beirut Medical Center, Beirut, Lebanon
18. Aga Khan University Hospital, Karachi, Pakistan
19. Sultan Qaboos University Hospital, Muscat, Oman
20. University of the Witwatersrand, Johannesburg, South Africa
21. Hebei Yanda Ludaopei Hospital, Langfang, China
22. Hopital 20 Aout, Casablanca, Morocco
23. Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan
24. Keio University School of Medicine, Tokyo, Japan
25. King Abdulaziz Medical City, NGHA, Riyadh, Saudi Arabia
26. African Blood & Marrow Transplantation Society (AFBMT), South Africa
27. Christian Medical College & Hospital, Bagayam, Vellore, India
28. Instituto de Oncologia Pediatrica, Sao Paulo, Brazil
29. Center for Hematopoietic Stem Cell Transplantation, Aichi Medical University Hospital, Nagakute, Japan
30. Medical University of Graz, LKH-Univ. Klinikum Graz, Austria
31. Department of Clinical Haematology, Royal Melbourne Hospital, 3050, VIC, Australia
32. Department of Hematology and Medical Oncology, University Hospital, Leipzig, Germany

Source: Hematology/ Oncology and Stem Cell Therapy Published:2020

Abstract

The development of hematopoietic stem cell transplantation (HSCT) programs can face significant challenges in most developing countries because such endeavors must compete with other government health care priorities, including the delivery of basic services. While this is may be a limiting factor, these countries should prioritize development of the needed expertise to offer state of the art treatments including transplantation, by providing financial, technological, legal, ethical and other needed support. This would prove beneficial in providing successful programs customized to the needs of their population, and potentially provide long-term cost-savings by circumventing the need for their citizens to seek care abroad. Costs of establishing HSCT program and the costs of the HSCT procedure itself can be substantial barriers in developing countries. Additionally, socioeconomic factors intrinsic to specific countries can influence access to HSCT, patient eligibility for HSCT and timely utilization of HSCT center capabilities. This report describes recommendations from the Worldwide Network for Blood and Marrow Transplantation (WBMT) for establishing HSCT programs with a specific focus on developing countries, and identifies challenges and opportunities for providing this specialized procedure in the resource constrained setting. © 2020 The Authors

2. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged 70 Years and Older: A Systematic Review and Meta-Analysis, Transplantation and Cellular Therapy (2025)

Experts (# of related papers)

Amir Ali Hamidieh (1)

Style	Citing Format
MLA	Aljurf M, et al.. "Worldwide Network for Blood and Marrow Transplantation (Wbmt) Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries With Limited Resources (Part Ii): Clinical, Technical and Socio-Economic Considerations." Hematology/ Oncology and Stem Cell Therapy, vol. 13, no. 1, 2020, pp. 7-16.
APA	Aljurf M, Weisdorf D, Hashmi SK, Nassar A, Gluckman E, Mohty M, Rizzo D, Pasquini M, Hamadani M, Saber W, Hari P, Kharfandabaja M, Majhail N, Gerges U, Ali Hamidieh A, Hussain F, Elhaddad A, Mahmoud HK, Tbakhi A, ... Niederwieser D (2020). Worldwide Network for Blood and Marrow Transplantation (Wbmt) Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries With Limited Resources (Part Ii): Clinical, Technical and Socio-Economic Considerations. Hematology/ Oncology and Stem Cell Therapy, 13(1), 7-16.
Chicago	Aljurf M, Weisdorf D, Hashmi SK, Nassar A, Gluckman E, Mohty M, Rizzo D, et al.. "Worldwide Network for Blood and Marrow Transplantation (Wbmt) Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries With Limited Resources (Part Ii): Clinical, Technical and Socio-Economic Considerations." Hematology/ Oncology and Stem Cell Therapy 13, no. 1 (2020): 7-16.
Harvard	Aljurf M et al. (2020) 'Worldwide Network for Blood and Marrow Transplantation (Wbmt) Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries With Limited Resources (Part Ii): Clinical, Technical and Socio-Economic Considerations', Hematology/ Oncology and Stem Cell Therapy, 13(1), pp. 7-16.
Vancouver	Aljurf M, Weisdorf D, Hashmi SK, Nassar A, Gluckman E, Mohty M, et al.. Worldwide Network for Blood and Marrow Transplantation (Wbmt) Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries With Limited Resources (Part Ii): Clinical, Technical and Socio-Economic Considerations. Hematology/ Oncology and Stem Cell Therapy. 2020;13(1):7-16.
BibTex	@article{ author = {Aljurf M and Weisdorf D and Hashmi SK and Nassar A and Gluckman E and Mohty M and Rizzo D and Pasquini M and Hamadani M and Saber W and Hari P and Kharfandabaja M and Majhail N and Gerges U and Ali Hamidieh A and Hussain F and Elhaddad A and Mahmoud HK and Tbakhi A and Othman TB and Hamladji RM and Bekadja MA and Ahmed P and Bazarbachi A and Adil S and Alkindi S and Ladeb S and Dennison D and Patel M and Lu P and Quessar AE and Okamoto S and Atsuta Y and Alhejazi A and Ayas M and Ahmed SO and Novitzky N and Srivastava A and Seber A and Elsolh H and Ghavamzadeh A and Confer D and Kodera Y and Greinix H and Szer J and Horowitz M and Niederwieser D}, title = {Worldwide Network for Blood and Marrow Transplantation (Wbmt) Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries With Limited Resources (Part Ii): Clinical, Technical and Socio-Economic Considerations}, journal = {Hematology/ Oncology and Stem Cell Therapy}, volume = {13}, number = {1}, pages = {7-16}, year = {2020} }
RIS	TY - JOUR AU - Aljurf M AU - Weisdorf D AU - Hashmi SK AU - Nassar A AU - Gluckman E AU - Mohty M AU - Rizzo D AU - Pasquini M AU - Hamadani M AU - Saber W AU - Hari P AU - Kharfandabaja M AU - Majhail N AU - Gerges U AU - Ali Hamidieh A AU - Hussain F AU - Elhaddad A AU - Mahmoud HK AU - Tbakhi A AU - Othman TB AU - Hamladji RM AU - Bekadja MA AU - Ahmed P AU - Bazarbachi A AU - Adil S AU - Alkindi S AU - Ladeb S AU - Dennison D AU - Patel M AU - Lu P AU - Quessar AE AU - Okamoto S AU - Atsuta Y AU - Alhejazi A AU - Ayas M AU - Ahmed SO AU - Novitzky N AU - Srivastava A AU - Seber A AU - Elsolh H AU - Ghavamzadeh A AU - Confer D AU - Kodera Y AU - Greinix H AU - Szer J AU - Horowitz M AU - Niederwieser D TI - Worldwide Network for Blood and Marrow Transplantation (Wbmt) Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries With Limited Resources (Part Ii): Clinical, Technical and Socio-Economic Considerations JO - Hematology/ Oncology and Stem Cell Therapy VL - 13 IS - 1 SP - 7 EP - 16 PY - 2020 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract